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Table
Median Cell Dose/kg Pre and Post TCD
Cells TNC CD34 CD3 CD4 CD8 TCR gd CD56/16
Pre BM 3.81E+08 5.87E+06 2.69E+07 1.32E+07 1.27E+07 1.26E+06 3.86E+06
Pre PBSC 1.19E+09 8.72E+06 2.38E+08 1.37E+08 2.59E+08 9.71E+06 3.59E+07
SBA-E- 2.84E+07 1.86E+06 6.07E+04 8.30E+03 4.04E+04 1.20E+04 6.73E+05
Iso E- 7.63E+06 7.31E+06 1.58E+03 3.88E+02 7.78E+02 <1.00E+02 2.25E+03
Clini 8.53E+06 1.05E+07 3.56E+03 2.06E+03 1.49E+03 <1.00E+02 6.98E+02
Abstracts / Biol Blood Marrow Transplant 19 (2013) S313eS341 S315T cells had a 1:1 ratio of CD4:CD8 while PBSC had a 1:2 ratio.
The table shows post TCD T cell doses were signiﬁcantly
higher in BM than in PBSC grafts. In TCD BM, the median log
10 depletion of CD3 + T cells (2.65) was signiﬁcantly different
from IsoE log10 TCD (5.22). Clini log 10 TCD (4.92) was
similar to IsoE. Strikingly, while preprocessed BM had fewer
NK CD56/16+ than PBSC (3.86E+06 vs. 3.59E+07), the nega-
tive selection of BM left more NK cells in the TCD graft,
resulting in signiﬁcantly higher NK cell dose (6.73E+05) than
after CD34+ positive selection by Iso E- (2.25E+03) or Clini
(6.98E+02). IsoE- had signiﬁcantly (P < .001) higher CD34
doses (7.31E+06 /kg) and greater recovery (85.0%) of CD34+
cells; than SBA-E- (1.86E+06 /kg, 33.3% recovery). Clini
selection resulted in similar CD34 cell doses and recovery to
the IsoE-. (1.05E+07/kg, 116.74 % recovery). Number and
types of CD3+ T cells, T subpopulations, NK, and CD34+ in
TCD grafts act in concert with donor and host parameters to
effect ﬁnal transplant outcome. Characterization of cells in
preprocessed grafts and retained by TCDmethods can lead to
better graft engineering and optimization of the cellular
content of the ﬁnal T depleted product.413
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The impact of the years of storage of an umbilical cord blood
unit (CBU) on its engraftment potency is not known. We
analyzed engraftment kinetics of 15 Old CBUs deﬁned as
stored for more than 5 years and compared it to 71 Younger
CBUs for end points of time to neutrophil and platelet
engraftment. The median duration of storage for the Old
CBUs was 5.6 years (5.6-12.2 years). For Old vs. Young CBUs,
the average total nucleated count was 0.5 x106 vs. 55x106 (P
¼ .004), cryopreservation volume of 72ml vs. 70ml (P ¼ .9),
CD34 count of 0.19x106/kg vs. 0.23x106/kg (P ¼ .7). There
were no differences in the processing of the CBUs. The donor
characteristics for the Old vs. Young CBUs were Caucasian
race: 7% vs. 24% (P < .0001)and female sex: 43% vs. 49% (P ¼
.3). The recipient characteristics for the Old vs. Young CBUs
were: female sex: 57% vs. 45% (P ¼ .4), Caucasian race 43% vs.
63% (P < .0001), recipient weight 30kg vs. 38kg (p¼NS),
recipient age 14 vs. 16 years (p¼NS). The transplant condi-
tioning, GVHD prophylaxis and degree of HLA mismatch was
comparable for the two groups. There were no differences in
the engraftment kinetics for the Old vs. Young CBUs with
time to neutrophil engraftment of 21 vs. 22 days (P ¼ .5);
platelet engraftment of 43 vs. 42 days (P ¼ .3). Early deaths
were comparable 7% vs. 6%, no differences were noted in the
duration of hospitalization. We conclude that Old CBUs
should remain as a potential source of stem cells.414
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Background: Ex vivo expanded CBTcells (with CD3/CD28 co-
stimulatory beads + IL-2 and IL-7) are receptive to subse-
quent in vitro priming against killed lymphoid and myeloid
leukemia cells in the presence of IL-7, IL-12, and IL-15. This
had been reported from our lab (Davis et al. Cancer Research
2010, 70(13): 5249).
Objectives:We tested 1) the minimum cytokine and priming
requirements, hypothesizing that higher speciﬁcity may be
obtained if fewer exogenous cytokine is employed. 2)
Determine the critical recognition element of cytotoxicity. 3)
Characterize the cellular phenotype associated with the CTL
activity.
Methods: CTL was generated from already expanded (<3% of
a typical cord blood graft) >98% pure T cells either with
a combination of cytokines IL-7, -12 & -15 (n¼4) versus IL-15
(n¼5), versus IL-7 (n¼3) alone. After 2nd and 3rd weeks of
CTL cultures, the cytotoxicity was tested against fresh IM9
leukemia cells using europium ligand (EuTDA) release assay.
The blocking with HLA class I & II and TCRgd antibodies were
done before performing the CTL assay (n¼3). ELISPOT assay
was done to test the speciﬁcity as measured by IFN-g spot
forming cells (SFC). Eight colors FACS analysis was done
using FACS canto II, to analyze the CTL's phenotype.
Results: After 3 weeks of priming, the mean speciﬁc lysis of
CTL generated using IL-15 alone versus combination of
cytokines on fresh IM9 cells was 79% and 80% respectively at
an E/T ratio of 40:1 (Figure-1). CTL generated using IL-15
alone has a speciﬁc lysis of 90% at the end of second priming
(n¼4). The CTL's exhibit no cytotoxicity against non-speciﬁc
targets (myeloid leukemia cell line U937). The expanded CBT
cells primed with IL-15 alone, but without being exposed to
IM9 cells did not acquire speciﬁc cytotoxicity (n¼4). While
cytotoxicity was comparable, CTL from IL-15 alone cultures
displayed higher speciﬁcity in ELISPOTassays with much less
non-speciﬁc target recognition as measured by IFN-g spot
forming cells (SFC) (n¼2).
Eventhough, no single blockingMoAb completely abolished
cytotoxicity, the most signiﬁcant diminution was identiﬁed
when the effectors were blocked with TCRgd. Multicolor
FACS analysis indicates that after exposing the CTLs to
speciﬁc targets, w6-7% of the cells are secreting IFN-g in
response and 6-20% are TCRgd positive. Immunoscope
analysis of TCRgd spectratype identiﬁes oligoclonal restric-
tion of CTL cultures with lytic activity compared to identical
cytokine expanded T cells lacking leukemiaespeciﬁc CTL
activity.
